Silvio Inderbitzin

Silvio Inderbitzin, Verwaltungsrat und Investor at Exentis Group AG is an active investor based in Lucerne, Switzerland. This profile covers what Silvio Inderbitzin backs, at which stage, and how founders can reach out in 2026.

Dr. Silvio Inderbitzin serves as Board Member at Exentis Group.He Inderbitzin serves as Chairman & Co-Owner at Mavena International. He serves as Board Member at ARTIDIS. He also serves as Chairman of the Board of Directors at Mavena International. He held different positions as a CEO, Member of the Board of Directors and co-owner. He serves as Board Member at obvioTec. He serves as Board Member at Polyphor, Aurealis Pharma and Strekin. He served as Board Member at ARTIDIS. He has held multiple senior positions in the pharmaceutical industry during the last 20 years. With his origin in pharmaceutical manufacturing, he built a corporate-wide GMP-quality assurance infrastructure as Head of Quality Assurance and was responsible for product release as a Qualified Person in a medium-sized Swiss pharmaceutical company. He was later elected to the position of Technical Director and served on the Corporate Management Team, ultimately joining the Board of Directors and becoming co-owner of the privately-held 450 employee company. Prior to the successful sale of the company, he served as a CEO and was responsible for its foreign subsidiaries. He is an active investor, consultant and board member of several life science start-up companies. He studied Pharmacy at the University of Berne, he holds a Ph.D. in Pharmacology from the University of Zurich/ETH and obtained an Executive MBA from the University of St. Gallen.

Notable investments

Lifeforce GmbHARTIDISAurealis TherapeuticsSciensus AG vorher High Tech Home CareUlrich Jüstrich Holding AGCuratis AG vormals Kinarus AGNEXILIS AGSpirig Pharma AGMavena International AGGalvita - AGHänseler AGStrekin AG